title: Follow up of infants born to women with hepatitis B in the National Maternity Hospital.
abstract: Infants born to women with hepatitis B virus (HBV) are at risk of vertical transmission. This risk is significantly reduced with correct post-natal treatment After initial perinatal management and neonatal treatment, these infants receive subsequent follow up HBV immunisations at two, four and six months. These infants then require post vaccination serological testing. This review was conducted to determine the number of infants born to mothers with HBV in the National Maternity Hospital who had appropriate post vaccination serological testing. There were seventy-eight HBV infections identified antenatally in the years 2010 and 2011 resulting in seventy live born infants at our institution. Thirteen (18.6%) infants had evidence of post vaccination serological testing. This is below international rates of follow up. There is an urgent need for a centralised national programme to ensure adequate follow up and management of all infants born to women with HBV in Ireland.
authors.forename: C P
authors.initials: CP
authors.lastname: Travers
authors.forename: J
authors.initials: J
authors.lastname: Connell
authors.forename: L
authors.initials: L
authors.lastname: Thornton
authors.forename: E
authors.initials: E
authors.lastname: Keane
authors.forename: S
authors.initials: S
authors.lastname: Knowles
authors.forename: J F A
authors.initials: JF
authors.lastname: Murphy
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology / Q000628:therapy / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006771:Hospitals, Maternity / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007494:Ireland / Q000453:epidemiology; D015166:Monitoring, Immunologic / Q000379:methods; D018743:Perinatal Care / Q000379:methods; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000453:epidemiology / Q000628:therapy; D012698:Serologic Tests / Q000379:methods; D014611:Vaccination / Q000379:methods
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines